Heparoid

Heparoid is a topical product that contains the anticoagulant heparinoid as its active ingredient. Marketed in the European Union, it is supplied in a cutaneous formulation whose exact strength and dosage form are not specified. The preparation is intended for external use on the skin, where it exerts local anticoagulant, anti‑inflammatory and anti‑edematous actions.

Heparoid is indicated for several superficial vascular and skin conditions where local anticoagulation or edema reduction is desired.

- Prevention and treatment of superficial thrombophlebitis. - Management of bruising, hematomas, and localized swelling. - Adjunct therapy for minor skin injuries that may develop clot formation. - Supportive care in conditions with localized inflammation and edema. - Use as a topical antithrombotic in selected dermatologic procedures.

Heparoid may cause local skin reactions as well as systemic effects if absorbed in significant amounts.

Common: - Mild skin irritation or redness at the application site. - Itching or mild pruritus. - Transient warmth or tingling sensation. - Minor bruising or discoloration. - Localized swelling that resolves spontaneously.

Serious: - Allergic dermatitis or severe skin rash. - Unexplained bleeding or bruising beyond the treated area. - Signs of systemic anticoagulation such as nosebleeds. - Development of necrotic skin lesions. - Severe hypersensitivity reactions including angioedema.

When using Heparoid, certain safety considerations should be observed to minimize risk.

- Apply only to intact, non‑infected skin unless directed by a healthcare professional. - Avoid use on large body surface areas or broken skin without medical supervision. - Do not combine with other topical anticoagulants unless advised. - Monitor for signs of excessive bleeding, especially in patients on systemic anticoagulants. - Pregnant or breastfeeding individuals should consult a clinician before use. - Discontinue if severe skin irritation or allergic reaction occurs.

Heparoid can interact with other agents that affect coagulation or skin integrity.

Avoid: - Concurrent use of systemic anticoagulants (e.g., warfarin, direct oral anticoagulants) without medical guidance. - Application over areas treated with other topical heparin products. - Use together with potent corticosteroid creams that may increase skin absorption.

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically. - Herbal or dietary supplements that have anticoagulant properties (e.g., ginkgo, garlic). - Patients with known bleeding disorders. - Individuals with severe liver disease affecting clotting factor synthesis.